New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A1209

Introduced
1/11/22  

Caption

Establishes Overdose Fatality and Near Fatality Review Board.

Goal

The primary objective of A1209 is to prevent overdoses through systematic reviews and identification of at-risk populations and effective intervention strategies. By promoting statewide collaboration, the board intends to foster a more responsive framework for addressing substance abuse and overdoses in New Jersey. The anticipated annual reports from the board will provide valuable insights and recommendations to the Governor and the Legislature, supporting ongoing efforts to enhance public health infrastructure.

Impact

The establishment of the board marks a significant step toward comprehensive state-level oversight of overdose cases. Notably, the board is intended to operate independently from the Department of Human Services despite being established within it. It will be empowered to review and assess overdose cases, maintaining a confidential master file of overdose and near fatality records. This aspect aims to enhance data gathering while ensuring a degree of privacy for individuals involved. The board's reviews and findings will play a crucial role in shaping public policy and improving the response of the state to substance use-related issues.

Summary

Assembly Bill A1209 proposes the establishment of the Overdose Fatality and Near Fatality Review Board in New Jersey, which is designed to address the alarming rates of overdose fatalities and near fatalities linked to substance use. The board will consist of 13 members, including government officials and public appointees, who will be tasked with identifying the causes of these tragedies and the relationship these incidents have with existing governmental support systems. The bill emphasizes a collaborative approach to understanding and preventing such incidents through inter-agency cooperation and community involvement.

Contention

While there is support for the bill due to its focus on improving public health outcomes, some concerns have been raised regarding the mechanisms of accountability and the extent of governmental reach into personal health matters. Critics argue that the potential for state overreach in reviewing personal medical records could deter individuals from seeking help for substance use disorders. Furthermore, the effectiveness of the board's recommendations and its ability to generate real change in preventing fatalities will be closely monitored by both supporters and detractors.

Companion Bills

No companion bills found.

Previously Filed As

NJ A1088

Establishes Overdose Fatality and Near Fatality Review Board.

NJ SB391

Opioid overdose fatalities; dissolving Overdose Fatality Review Board; providing for Attorney General oversight. Effective date. Emergency.

NJ SB391

Opioid overdose fatalities; dissolving Overdose Fatality Review Board; providing for Attorney General oversight. Effective date. Emergency.

NJ HB1042

Sunset; Opioid Overdose Fatality Review Board; extending sunset year.

NJ HB1042

Sunset; Opioid Overdose Fatality Review Board; extending sunset year.

NJ SB5643

Expanding the purview of child fatality and near fatality reviews.

NJ H2727

Relative to overdose fatalities

NJ HB515

Public Health - Local Drug Overdose Fatality Review Teams - Membership

NJ HB0515

Public Health - Local Drug Overdose Fatality Review Teams - Membership

NJ A1560

Provides for identification and study of infant fatalities and near fatalities resulting from vaccination; requires inclusion of vaccination information in sudden infant death reports; and requires use of federal infant death reporting form.

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.